1. Stocks
    2. /
  2. Clarity Pharmaceuticals (ASX: CU6)
    3. /

Clarity Pharmaceuticals (ASX: CU6) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Clarity Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Clarity Pharmaceuticals (ASX: CU6)
    Latest News

    A man looking at his laptop and thinking.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a disappointing hump day session for the ASX today.

    Read more »

    Three healthcare workers look and point at at medical image
    Share Market News

    Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors

    | Bronwyn Allen

    Pro Medicus shares just keep on going, rising 625% over the past three years.

    Read more »

    Hands reaching high for a trophy with a sunset in the background.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a cracking end to the trading week for ASX investors.

    Read more »

    Hiker man backpacker with hands up in the summer mountains with cloudy sky.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a tantalising day for the ASX 200 this Tuesday.

    Read more »

    Person pretends to types on laptop drawn in sand.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a disappointing end to the trading week for investors this Friday.

    Read more »

    Man with backpack spreading his arms out and soaking in the sun.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a disappointing session for investors today.

    Read more »

    Ten smiling business people wave to the camera after receiving some winning company news.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    ASX investors enjoyed a strong recovery day this Tuesday.

    Read more »

    A male investor wearing a blue shirt looks off to the side with a miffed look on his face as the share price declines.
    Share Fallers

    Why ANZ, Clarity, IGO, and Pilbara Minerals shares are dropping today

    | James Mickleboro

    These shares are ending the week in the red. But why?

    Read more »

    a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
    Share Gainers

    Why Clarity Pharmaceuticals, Kelsian, Life360, and Syrah shares are rising today

    | James Mickleboro

    These shares are pushing higher on Thursday. But why?

    Read more »

    A couple stares at the tv in shock, with the man holding the remote up ready to press a button.
    Speculative

    Why this speculative ASX stock could rise 100%+

    | James Mickleboro

    Big returns could be on offer here according to Bell Potter.

    Read more »

    A young woman holding her phone smiles broadly and looks excited, after receiving good news.
    Share Gainers

    Why Bannerman Energy, Clarity, DroneShield, Lotus Resources are charging higher

    | James Mickleboro

    These shares are making their shareholders smile on Tuesday. But why?

    Read more »

    Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a volatile, but negative day for ASX investors this Thursday.

    Read more »

    CU6 ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Clarity Pharmaceuticals

    Clarity Pharmaceuticals Ltd. is a clinical stage radiopharmaceutical company. It engages in research and development and clinical stage evaluation of its portfolio of novel radiopharmaceuticals products. The company was founded by Matthew Harris on April 8, 2010 and is headquartered in Eveleigh, Australia.

    Profile

    since

    Note